VPMA, Chief Patient Safety Officer
Pediatric Hematology & Oncology
Dr. Brigitta U. Mueller, MD
|
|
Give Review
Brigitta Mueller practices Pediatric Hematology & Oncology. She over the years received 1 awards: "Fellow (FAAP)". Brigitta U. Mueller, MD has written publications. She has 68 publications published with PubMed. The lastest paper is: 'Low-grade monoclonal Epstein-Barr virus-associated lymphoproliferative disorder of the brain presenting as human immunodeficiency virus-associated encephalopathy in a ...'
Publications
- Quality and safety in pediatric hematology/oncology.
- Pain and other non-neurological adverse events in children with sickle cell Anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions ...
- Trends in blood transfusion among hospitalized children with Sickle cell disease.
- Parental information, motivation, and adherence behaviors among children with Sickle cell disease.
- The second century of Sickle cell disease.
- The medical home experience among children with Sickle cell disease.
- Shorter hospitalization trends among children with Sickle cell disease.
- Translating scientific advances to improved outcomes for children with Sickle cell disease: a timely opportunity.
- High resource hospitalizations among children with vaso-occlusive crises in Sickle cell disease.
- Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with Sickle cell disease.
- Hydroxyurea for children with Sickle cell disease: are we starting too late?
- Respiratory symptoms and acute painful episodes in Sickle cell disease.
- Oral iron chelation and the treatment of iron overload in a pediatric hematology center.
- Healthcare utilization and expenditures for low income children with Sickle cell disease.
- When should hydroxyurea be used for children with Sickle cell disease?
- A critical assessment of transcranial doppler screening rates in a large pediatric Sickle cell center: opportunities to improve healthcare quality.
- Day hospital versus inpatient management of uncomplicated vaso-occlusive crises in children with Sickle cell disease.
- Treatment of uncomplicated vaso-occlusive crises in children with Sickle cell disease in a day hospital.
- Analgesic Response to Morphine in Children with Sickle Cell Disease: A Pilot Study.
- Effects of Patient Controlled Analgesia Hydromorphone during Acute Painful Episodes in Adolescents with Sickle Cell Disease: A Pilot Study.
- Pain experience of children with Sickle cell disease who had prolonged hospitalizations for acute painful episodes.
- Prolonged QT interval in pediatric Sickle cell disease.
- Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura.
- Increased pulmonary artery pressures among adolescents with Sickle cell disease.
- Thromboelastographic and hemostatic characteristics in pediatric patients with Sickle cell disease.
- Outcomes for children with gallbladder abnormalities and Sickle cell disease.
- A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in Sickle cell disease.
- Assessment of cardiac iron by MRI susceptometry and R2* in patients with Thalassemia.
- One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximab.
- Hemoglobin H-constant spring in North America: an alpha Thalassemia with frequent complications.
- Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in Sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomize...
- A phase I/II study of the protease inhibitor indinavir in children with HIV infection.
- A phase I/II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infection.
- Bone marrow aspirates and biopsies in children with human immunodeficiency virus infection.
- PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding.
- Combination treatment with azidothymidine and granulocyte colony-stimulating factor in children with human immunodeficiency virus infection.
- Disseminated intravascular coagulation associated with granulocyte colony-stimulating factor therapy in a child with human immunodeficiency virus infection.
- Zidovudine and didanosine combination therapy in children with human immunodeficiency virus infection.
- Pancreatitis in human immunodeficiency virus-infected children receiving dideoxyinosine.
- Pharmacokinetic evaluation of the combination of zidovudine and didanosine in children with human immunodeficiency virus infection.
- Prevention of red cell dehydration: a possible new treatment for Sickle cell disease.
- Clinical and pharmacokinetic evaluation of long-term therapy with didanosine in children with HIV infection.
- Phase I study of continuous-infusion soluble CD4 as a single agent and in combination with oral dideoxyinosine therapy in children with symptomatic human immunodeficie...
- A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer ...
- Long-term protease inhibitor-containing therapy results in limited improvement in T Cell function but not restoration of interleukin-12 production in pediatric patient...
- HIV-associated malignancies in children.
- The infant with a vascular tumor.
- Antiviral chemotherapy.
- Cancers in human immunodeficiency virus-infected children.
- Immunoreconstitution after ritonavir therapy in children with human immunodeficiency virus infection involves multiple lymphocyte lineages.
- Multilocular thymic cysts in children with human immunodeficiency virus infection: clinical and pathologic aspects.
- Pneumocystis carinii pneumonia despite prophylaxis in children with human immunodeficiency virus infection.
- Comparison of virus burden in blood and sequential lymph node biopsy specimens from children infected with human immunodeficiency virus.
- Smooth muscle tumors in children with human immunodeficiency virus infection.
- Defining the population of human immunodeficiency virus-infected children at risk for Mycobacterium avium-intraCellulare infection.
- Cancer in children with primary or secondary immunodeficiencies.
- Low-grade monoclonal Epstein-Barr virus-associated lymphoproliferative disorder of the brain presenting as human immunodeficiency virus-associated encephalopathy in a ...
- Cytomegalovirus infection in children with human immunodeficiency virus infection.
- Serum and cerebrospinal fluid pharmacokinetics of intravenous and oral lamivudine in human immunodeficiency virus-infected children.
- Cancers in children infected with the human immunodeficiency virus.
- Pharmacokinetics of the protease inhibitor KNI-272 in plasma and cerebrospinal fluid in nonhuman primates after intravenous dosing and in human immunodeficiency virus-...
- Role of tissue diagnosis in pulmonary involvement in pediatric human immunodeficiency virus infection.
- Pneumocystis carinii presenting as a mediastinal mass in a child with acquired immunodeficiency syndrome.
- Pseudomonas infections in children with human immunodeficiency virus infection.
- Cancer in human immunodeficiency virus-infected children: a case series from the Children's Cancer Group and the National Cancer Institute.
- Integration of Administrative Data and Chart Review for Reporting Health Care Utilization Among Children With Sickle Cell Disease.
- Association of care in a medical home and health care utilization among children with Sickle cell disease.
Conditions Treated
- Anemia
- Neutropenia
- Osteosarcoma
- Sickle Cell Disease
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Awards
- Fellow (FAAP)
Education
-
Harvard School of Public Health -
Boston Children's Hospital -
National Institutes of Health Clinical Center -
University of Bern Faculty of Medicine
Hospital
-
All Children's Hospital Johns Hopkins Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Colin E. Moore, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lele Aung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gauravi K. Majmundar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aleksandra Petrovic, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Colin Moore, MD
This Doctor is OpenDoctor Recommended.
|